ArticleCancers2021

Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.

Che-Jui Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.